Ocugen, Inc. (OCGN)
0.9445
-0.03
(-2.84%)
USD |
NASDAQ |
Nov 10, 16:00
0.9445
0.00 (0.00%)
After-Hours: 20:00
Ocugen Cash from Operations (Annual) : -56.96M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -56.96M |
| December 31, 2024 | -42.14M |
| December 31, 2023 | -62.05M |
| December 31, 2022 | -60.08M |
| December 31, 2021 | -47.94M |
| December 31, 2020 | -14.71M |
| December 31, 2019 | -16.89M |
| Date | Value |
|---|---|
| December 31, 2018 | -11.63M |
| December 31, 2017 | -23.02M |
| December 31, 2016 | -25.74M |
| December 31, 2015 | -30.03M |
| December 31, 2014 | -18.40M |
| December 31, 2013 | -15.28M |
| December 31, 2012 | -12.23M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Anika Therapeutics, Inc. | 11.19M |
| Nektar Therapeutics | -208.51M |
| Heron Therapeutics, Inc. | -27.59M |
| TG Therapeutics, Inc. | -24.77M |
| Tonix Pharmaceuticals Holding Corp. | -99.84M |